Clinical Genomics Workspace

Streamlined clinical decision support for laboratories

Our tertiary analytics & reporting tool for clinical NGS laboratories, powered by our best-in-class Knowledge Base and connected to our Seven Bridges platform for secondary analysis if needed

Request a demo

The Clinical Genomics Workspace at a glance

Velsera's Clinical Genomics Workspace (CGW) supports the process of creating a clinical NGS report, from secondary analysis through draft reporting generation and sign out by a medical professional. CGW utilizes our state-of-the-art Knowledgebase to enable laboratories to engage in the practice of medicine and assemble clinical content for each patient. Once the report is complete, users can export results in both structured data formats (EMR/EHR integration) and as PDF reports.

CGW is disease, assay, instrument, and site-agnostic. Our NGS workflow and reporting platform optimizes your workflow from QA/QC review to facilitating rapid interpretation of NGS testing results, including supporting therapy recommendations, prognostic and diagnostic information, and matches to clinical trials. This empowers you to deliver precise medical management at every step of your patient’s journey.

Why use our Clinical Genomics Workspace

Better, Faster, Simpler.

Put simply, CGW helps you make better clinical reports, faster and with less effort.

Better

Make the best possible recommendation for the patient

Best-in-class knowledge base: Our approach to clinical evidence collection, aggregation, and assembly focuses on a higher standard of quality, richer depth, and better curation than any of our competitors. In this area, we are in a class of one.
Learn more >
Interpretation library: Over 90% of our customers have opted in to sharing their (de-identified) variant interpretations so you can see how others have interpreted in the past, including some of the leading institutions in the world. That’s 200,000+ interpretations to learn from!
Complex interpretations: Our latest software can deal with complex interpretations, such as cooccurrence of gene variants, enabling a better decision about patient care.

Faster

Reduce reporting & turnaround time

Comprehensive end-to-end management of NGS results – manage secondary and tertiary analysis, review sequence data quality and variant quality, interpretation, and reporting to an electronic health record system—all within a single seamless workflow.
Actionable clinical reporting - CGW helps you create customizable clinical reports that enable faster patient care. With interpretations grounded in evidence from trusted sources, you can focus on delivering optimal therapeutic options and advancing your clinical genomics program.
CGW learns with you – as you classify variants within a specific disease context CGW can learn with you so that next time you see that variant in that same context the default classification is applied

Simpler

Minimize your activation effort

Fully integrated - CGW offers powerful interpretation and reporting capabilities, along with clinical and research systems integration. Utilizing messaging standards and application programming interfaces, CGW streamlines the delivery of results and increases your lab’s data organization and accessibility. It integrates seamlessly with:
- Electronic Health Records (EHR)
- Lab Information Management Systems (LIMS)
- Enterprise Data Warehouses (EDW)
Fully supported – our in-house teams of clinical, regulatory and technology experts can help you get up and running fast

Who we help accelerate

Customers for this technology

Clinical Diagnostic Laboratories

Accelerate the scale-up of your NGS testing

Grow revenue by expanding your NGS business. Velsera helps diagnostic labs rapidly establish and grow new, profitable NGS revenue streams. With our support, we can help your lab get up-and-running with an existing on-market assay (20+ LDT & IVD options available), including support for validation, revenue cycle management, and our Clinical Genomics Workspace (CGW) software to aid clinical decision-making.

Learn more

NGS Assay & Equipment Manufacturers

BRING NEW TESTS AND EQUIPMENT TO MARKET

Have you got a promising diagnostic test in development? Or do you have novel equipment that you want to drive uptake of in the clinical setting? Velsera can partner with you to bring new, promising tests to market by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, we can help your future laboratory customers with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement – increasing the uptake from customers. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.

Learn more

Biotech & Pharma

ACCELERATE UPTAKE OF YOUR UPCOMING LAUNCH

Don’t wait until the last minute to design and develop your Companion Diagnostic (CDx) – it literally is the rate limiting gate keeper to scaling your new therapy! Velsera can partner with you to design and develop your test by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, once live in the market, we can help labs with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement – increasing the uptake from customers. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.

Learn more

Solutions

Solutions this platform supports

Clinical Interpretation & Reporting

Accelerate the scale-up of your NGS testing

Learn more

NGS Assay Development & Expansion

Develop new tests to meet unmet needs

Has your lab recognized an unmet need in the market? Velsera helps ambitious diagnostic labs generate revenue by creating, integrating, hosting and/or deploying custom-developed NGS analysis pipelines. Additionally, we help with validation and regulatory support to ensure compliance, as well as Revenue Cycle Management support to enable reimbursement. Optionally, tertiary CGW reporting is available to create a fully integrated secondary & tertiary analysis package for your test.

Learn more

IVD Compliance Transition

Navigate regulatory uncertainty

Don’t let compliance challenges impede your progress. Velsera assists labs in navigating the FDA clearance process for both new assays and existing Laboratory Developed Tests (LDTs). We provide the necessary “dry-lab” component for approved products, along with optional tertiary reporting to enhance your workflow.

Learn more

Companion Diagnostic Development & Scaling

Accelerate uptake of your upcoming launch

Learn more

Real-world impact, trusted partnerships

“The Clinical Genomics Workspace (CGW) by Velsera has provided our laboratory with a seamless, integrated software solution that allows us to spend more time analyzing the sequencing data and generating clinical reports and less time worrying about logistics.”

James Patrick Solomon, M.D., Ph.D.

Medical Director, Clinical Genomics Laboratory / Weill Cornell Medicine